The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...
The Food and Drug Administration (FDA) has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin ... use prefilled pen; the prefilled pen dials in 1-unit increments.
Merilog is approved as both a 3 mL single-patient-use prefilled pen and a 10 mL multiple-dose vial. Like Novolog, Merilog should be given subcutaneously within 5-10 minutes prior to the start of a ...
The approval is for both a 3 milliliter single-patient-use prefilled pen and a 10 milliliter multiple-dose vial. Like Novolog, Merilog should be administered within five to 10 minutes before eating.
New Delhi: Sanofi has received U.S. Food and Drug Administration (FDA) approval for Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for ... both a 3 mL single-patient-use ...
Like Novolog, Merilog should be administered ... data published in JAMA Network Open shows that insulin pens could be produced for as little as $0.94 per unit and remain profitable, yet current ...
WEDNESDAY, Feb. 19, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart ... Both a 3-mL ...
The U.S. Food and Drug Administration (FDA) has approved Merilog, a biosimilar to the widely used insulin product Novolog (insulin ... patient-use prefilled pen and a 10-milliliter multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback